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DITORIAL
‘It is better  to  know  some  of the questions  than  all  of
he answers’’.  The  diagnosis  of the Obstructive  Sleep
pnea/Hypopnea Syndrome  by  questionnaires
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Fig.  1  A  proposal  for  integrating  the  impact  of  obstructive
sleep  apnoea  (deﬁned  as  an  apnoea/hypopnoea  index  of  >  15  on
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tany  attempts  have  been  made  over  the  decades  to  develop
redictive  models  for  the  presence  of  obstructive  sleep
pnoea  (OSA)  within  the  community  and  for  gauging  the
everity  of  the  condition  in  order  to  more  accurately  assess
esponses  to  a  variety  of  treatments,  ranging  from  continu-
us  positive  airway  pressure  to  weight  loss  strategies.  None
f  these  models  have  succeeded  in  demonstrating  the  nec-
ssary  sensitivities  and  speciﬁcities  to  be  deployed  in  real
ractice  although  they  may  occasionally  be  helpful  in  high-
ighting  the  possible  existence  of  obstructive  sleep  apnoea
OSA)  in  non-sleep  medicine  clinics,  e.g.  surgical  clinics,
ardiology  clinics.1
Obstructive  sleep  apnoea  hypopnoea  syndrome  (OSAHS)
s  a  complex  disease  which  can  present  in  a  variety  of  dif-
erent  ways  and  contribute  to  the  development  of  a number
f  comorbidities  (see  Fig.  1).  This  complexity  may  explain
hy  even  some  of  the  most  creative  attempts  at  predicting
nd  simplifying  diagnosis  have  been  failed.2
On  a  clinical  level,  history  and  examination  alone,  includ-
ng  blood  pressure  and  body  mass  index  (BMI)  measurement
an  predict  the  presence  of  OSAHS  in  about  50%  of  patients
ttending  a  specialised  sleep  clinic.3 However,  deﬁnitive
iagnosis  requires  objective  monitoring  during  sleep  using
ither  polygraphy  or  polysomnography.  When  screening  for
SAHS  either  in  clinical  settings  or  the  general  popula-
ion,  several  algorithms  have  been  developed  over  the  years
o  more  accurately  identify  its  presence  in  patients  pre-
enting  with  suggestive  complaints.  These  include  using  a
ombination  of  clinical  variables  such  as  BMI,  neck  circum-
erence,  jaw  structure,  the  presence  of  snoring,  reports
f  nocturnal  breathing  disturbances  and  the  presence  of
ypertension.  Whilst  the  sensitivity  of  these  approaches  may
e  high  (78-95%)  the  speciﬁcity  remains  low  (41-63%).4 A
ecent  meta-analysis  of  screening  questionnaires  used  in
 total  of  1,484  subjects 5included  4  studies  utilising  the
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nder the CC BY-NC-ND license (http://creativecommons.org/licenses/bolysomnography)  on  end-organ  damage  and  daytime  function
After:  Fig.  2.  Reference  2).
erlin  questionnaire,6 2  studies  using  the  Wisconsin  Sleep
uestionnaire,7 1  study  using  the  STOP  questionnaire 8 and
ne  the  STOP-BANG  questionnaire.5 Four  studies  of  patients
eferred  to  a  sleep  clinic  arrived  at  a  pooled  sensitivity  of
3%  (95%  CI,  66-78%)  for  the  diagnosis  of  OSAHS  and  a  pooled
peciﬁcity  of  61%  (95%  CI,  55-67%).  Six  studies  on  patients
ithout  symptoms  of  OSA  revealed  a  pooled  sensitivity  of
7%  (95%  CI,  73-80%)  for  detecting  OSAHS  and  a  pooled  speci-
city  of  53%  (95%  CI,  50-57%).5 Questionnaires  devised  over
he  last  25  years  to  evaluate  both  sleepiness  and  quality
f  life  in  OSAHS  have  included  the  Functional  Outcomes
f  Sleep  Questionnaire,10 the  Calgary  Sleep  Apnoea  Quality
f  Life  Index  (SAQLI),11 the  short  SAQLI 12and  the  Epworth
iedade Portuguesa de Pneumologia. This is an open access article
y-nc-nd/4.0/).
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Sleepiness  Score.13 The  latter  is  probably  the  most  widely
utilised  questionnaire  world-wide  in  the  practice  of  sleep
medicine.  Unfortunately,  correlation  with  objective  meas-
ures  of  sleepiness  is  poor  and  the  questions  themselves  very
open  to  misinterpretation.12 Even  the  pESS 14developed  to
obviate  some  of  these  problems  carries  the  same  degree
of  concerns  regarding  the  accuracy  with  which  respondents
note  their  answers.
In  Pataka’s  et  al.15 paper  published  in  this  issue,
an  attempt  was  made  to  combine  a  number  of  well-
established  questionnaires  used  for  screening  OSAHS  with
the  number  and  degree  of  oxygen  dips  using  oximetry,  ver-
iﬁed  using  attended  polysomnography.  Neither  the  Berlin
Questionnaire,6 nor  the  STOP-BANG  questionnaire 9were
found  to  be  useful  which  is  unsurprising  in  a  population  of
both  males  and  females  with  suspected  OSAHS.  The  sen-
sitivity  and  speciﬁcity  of  oximetry  was  found  to  be  high,
but  again,  this  too  is  hardly  surprising  in  the  context  of
a  supervised  in-lab  study.  A  recent  publication,  addressing
the  existing  publications  on  sleep  questionnaires  and  sleep
diaries,16 discussed  the  possible  cost  reduction  of  using  ques-
tionnaires  when  compared  to  Type  I  --  Type  III.  This  may
explain  the  current  widespread  interest  in  sleep  question-
naires.  At  present  there  appears  to  be  a  tendency  in  primary
care  medicine  to  use  questionnaires  and  not  a  standardized
history  in  assessing  for  the  presence  or  absence  of  OSAHS.
While  this  method  is  a  time-  and  therefore  cost-saving  pro-
cedure,  it  remains  to  be  proven  if  such  an  approach  will
really  reduce  public  spending  due  to  its  low  speciﬁcity.
Oximetry  is  used  in  many  centres  as  a  screening  tool  for
the  presence  of  OSA  in  combination  with  a  clinical  history
or  suspicion  for  the  disorder,  there  are  certain  caveats  that
need  to  be  borne  in  mind.  Not  all  oximeters  are  created
equal,  despite  great  advances  in  technology  in  recent  times.
There  is  also  no  minimal  speciﬁcation  on  signal  processing
in  the  context  of  sleep  breathing  disorders  either  nation-
ally  or  internationally.  The  minimum  standard  criteria  set
by  the  AASM  are  a  sampling  rate  of  25  Hz  with  averag-
ing  of  3  values.17 A  resolution  of  0.1%  is  desirable  but  not
speciﬁed  and  device  speciﬁc  signalling  processing  can  dif-
fer  substantially  among  oximeters.18 An  understanding  of
SpO2  waveforms  morphologies  is  essential  in  order  to  inter-
pret  the  output  appropriately,  as  is  a  knowledge  of  what  is
normal  and  abnormal  throughout  the  lifespan.19 Automated
systems  may  not  be  reliable  and  there  may  be  problems  with
blood  ﬂow,  haemoglobinopathies  and  tissue  optics  in  the
very  obese.  Movement  artefact  can  also  affect  the  readings
depending  on  whether  the  study  is  attended  or  unattended
and  measurement  inaccuracies  of  ±  2%  SpO2  should  be  fac-
tored  into  the  outputs.  A  large  number  of  studies  have  been
undertaken  over  the  decades  in  OSA  patients  suggesting
a  31-100%  sensitivity  and  41-100%  speciﬁcity;20 informa-
tion  which  suggests  just  how  unreliable  the  technique  can
be.  Finally,  a  normal  SpO2  does  not  exclude  OSA  as  many
hypopnoeas  and  apnoeas  may  not  be  accompanied  by  desat-
uration  and  an  abnormal  SpO2  does  not  automatically  signify
OSA.
Pataka  et  al.  deployed  in  their  study  continuous  positive
airways  pressure  (CPAP)  therapy  in  their  moderate-severe
1135
SAHS  patients  (AHI≥15)  or  in  those  with  an  AHI≥5  with
ymptoms  of  daytime  sleepiness,  irrespective  of  the  man-
er  in  which  they  were  identiﬁed.  This  is  in  keeping
ith  current  treatment  strategies  although  CPAP  does  not
niformly  improve  symptoms  in  unselected  patients  with
SAHS,  nor  consistently  prevent  or  improve  cardiometabolic
bnormalities.2 Pataka’s  et  al.  study  conﬁrms  that  CPAP
herapy  itself  is  important  as  part  of  the  diagnostic  pathway
n  establishing  the  relationship  between  symptom  proﬁle
nd  OSA  irrespective  of  how  the  diagnosis  was  arrived
t.  Should  symptoms  not  improve  despite  adequate  CPAP
ompliance,  they  may  be  due  to  other  factors  which  have
ot  been  taken  into  consideration  at  the  outset  or  which  may
rove  stronger  predictors  of  other  therapeutic  strategies.
e  look  forward  to  future  studies  from  this  group  examining
hese  models.
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